Skip to content

Comparison between two neuromuscular blockade reversal agents by ultrasonographic assessment

A randomized study to compare sugammadex with neostigmine for recovery of muscle function by ultrasonographic assessment in patients undergoing laparoscopic cholecystectomy - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054581
Enrollment
60
Registered
2023-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K800- Calculus of gallbladder with acutecholecystitis

Interventions

Intervention1: Sugammadex: Patients will receive sugammadex for reversal of neuromuscular block in dose 2mg/kg in immediate post surgery period at the time of reversal Control Intervention1: Neostigmi

Sponsors

Lady Hardinge Medical College and Associated Hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 18-65 years old 2. Patients of either sex 3. ASA I and ASA II 4. Patients undergoing laparoscopic cholecystectomy

Exclusion criteria

Exclusion criteria: 1.Patients with central or peripheral nervous system diseases, such as polio, parkinsonâ??s disease, peripheral neuropathy, etc. 2.Patients with neuromuscular diseases, such as myasthenia gravis, multiple sclerosis, atrophic myotonia, etc. 3. Patients with hepatic/renal disorders 4. Patients with BMI > 30 5.Patients with known history of allergy to drugs used in the study 6.Patients taking oral contraceptive pills

Design outcomes

Primary

MeasureTime frame
Comparison of mean percentage change in diaphragm thickening fraction (DTF) from baseline to 30 minutes post-operatively between the both groupsTimepoint: 30 minutes post-operatively

Secondary

MeasureTime frame
1.Mean percentage change in diaphragmatic excursion (DE) from baseline to 30 minutes post-operatively 2.Mean percentage change in internal oblique muscle thickening fraction (IO TF) from baseline to 30 minutes post-operativelyTimepoint: 1.30 minutes post-operatively 2.30 minutes post-operatively

Countries

India

Contacts

Public ContactDr Nishant Kumar

Lady Hardinge Medical College and Associated Hospitals

anug71@yahoo.in9711000264

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026